SAN DIEGO, June 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, all dates inclusive (the "Class Period"), have until August 11, 2025 to...
Read More Details
Finally We wish PressBee provided you with enough information of ( RCKT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Anne Burrell's Husband Looks Somber in First Photo Since Food Network Star's Death
- Iran threatens US bases in Middle East, asserts nuclear facilities undamaged
- Las negociaciones “no tienen sentido” a menos que Israel detenga los ataques, dice un portavoz del Gobierno iraní a CNN